Mortality from benign prostatic hyperplasia: worldwide trends 1950-92

Area of Science:

• Gerontology and Geriatric Medicine
• Urology
• Public Health and Epidemiology

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Understanding global mortality trends in BPH is crucial for public health initiatives.
• Historical data on BPH mortality provides insights into the impact of medical interventions.

Purpose of the Study:

• To systematically analyze worldwide mortality trends associated with benign prostatic hyperplasia (BPH).
• To examine changes in BPH mortality rates over a four-decade period (1950-1992).
• To identify geographical variations in BPH mortality trends.

Main Methods:

• Descriptive analysis of age-adjusted mortality rates for BPH.
• Data sourced from official death certifications via the World Health Organization database.
• Analysis covered 41 countries across five continents from 1950 to 1992.

Main Results:

• Significant decline in BPH mortality observed globally, exceeding 90-95% in Western Europe by 1990.
• Mortality rates in Western Europe dropped from over 20/100,000 in the 1950s to 0.5-1.5/100,000 by the early 1980s.
• Similar reductions noted in North America, Asia, and Oceania; smaller decreases seen in Eastern Europe and Latin America.

Conclusions:

• Therapeutic advancements, including surgical and medical treatments, are strongly linked to reduced BPH mortality.
• Widespread adoption of less invasive procedures like transurethral prostatectomy has likely contributed to favorable outcomes.
• Persistent high BPH mortality rates in certain areas of Western Europe and South America warrant further investigation and intervention.